Carbylan Therapeutics, Inc. — Form D

Carbylan Therapeutics, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-01-03. The offering totals $13.2M, of which $6.0M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
STEVEN BASTADirectorBRIDGEWATER, NJ
Albert ChaDirectorPALO ALTO, CA
George DaniloffDirectorPalo Alto, CA
Chris EhrlichDirectorSouth San Francisco, CA
Guy NohraDirectorSan Clemente, CA
George DaniloffExecutive OfficerPalo Alto, CA
Roxanne DuboisExecutive OfficerPalo Alto, CA
David GravettExecutive OfficerPalo Alto, CA
Marcee MaroneyExecutive OfficerPalo Alto, CA
Mark WeeksExecutive OfficerMENLO PARK, CA
Keith A KatkinDirectorSan Diego, CA
Albert L ChaDirectorMenlo Park, CA
Steven L BastaDirectorMenlo Park, CA
DAVID W CLAPPERDirectorPALO ALTO, CA
EDWARD W UNKARTDirectorPALO ALTO, CA
MARCEE M MARONEYExecutive OfficerPALO ALTO, CA
DAVID M GRAVETTExecutive OfficerPALO ALTO, CA
T. MICHAEL WHITEExecutive OfficerPALO ALTO, CA
REZA P ZADNODirectorPALO ALTO, CA
HAYLEY M LEWISExecutive OfficerPALO ALTO, CA
DAVID M RENZIDirectorPALO ALTO, CA
DAVID M RENZIExecutive OfficerPALO ALTO, CA
TIMOTHY L TRAPPExecutive OfficerPALO ALTO, CA
Guy P NohraDirectorSan Francisco, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2015-03-05D$4.0M$4.0M
2014-10-14D$5.0M$5.0M

More